Press Releases

NEW YORK, Jan. 9, 2020 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, is pleased to provide the following letter to shareholders from Chief Executive Officer

LAUSANNE, Switzerland, Jan. 9, 2020 /PRNewswire/ -- The French health-tech company Novadiscovery, which performs in silico trials for pharma and biotech companies with the aim of reducing research & development (R&D) costs and time-to-market of novel drugs, has closed the first 5 million eur

ALISO VIEJO, Calif., Jan. 9, 2020 /PRNewswire/ -- MicroVention, Inc., a U.S. based subsidiary of Terumo and a global neurovascular company announced the FDA Premarket Approval (PMA) for the FRED® (Flow Re-Direction Endoluminal Device) device for the treatment of brain aneurysms.  The FRED® device is the first flow diverter in the U.S.

JERUSALEM, Jan. 9, 2020 /PRNewswire/ -- Intec Pharma Ltd. (NASDAQ: NTEC) ("Intec" or "the Company") today provides a business and clinical update on its development programs with the Company's proprietary oral drug delivery system, the Accordion Pill® platform, in a Letter to Shareholders. The full text of the letter is below. Dear

MINNEAPOLIS, Jan. 9, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call on Tuesday, February 4, 2020, at 8:00 a.m. CST to review second quarter 2020 financial results.Access to the discussion may be obtained as follows:

CHICAGO, Jan. 9, 2020 /PRNewswire/ -- American Brain Tumor Association (ABTA) today announced a new partnership with the Uncle Kory Foundation to accelerate brain tumor research. Through this partnership, the Uncle Kory Foundation will invest $100,000 in the ABTA research program to fund two glioblastoma research projects. For more than

SAN DIEGO, Jan. 9, 2020 /PRNewswire/ -- Omniome, Inc., developer of an innovative DNA sequencing platform capable of delivering unsurpassed sequencing accuracy, today announced it has raised an additional $60 million with the completion of its Series C financing. The funding round was led by Madrone Capital Partners. Current i

WASHINGTON, Jan. 9, 2020 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will be presenting at the J.P. Morgan Healthcare Conference in San Francisco, California on Tuesday, January 14, 2020 at

NEW YORK, Jan. 9, 2020 /PRNewswire/ -- Eight leading care delivery systems from across the country have been designated as founding charter members of NASHNET and Centers of Excellence (COEs). In partnership with The Kinetix Group, a care delivery consultancy, the COEs are exploring ways to define and spread care delivery best practices for non-alcoholic fatty liver dise

IRVINE, Calif., Jan. 9, 2020 /PRNewswire/ -- Bioniz Therapeutics, Inc., a privately held clinical stage biopharmaceutical company developing first-in-class multi-cytokine peptide therapeutics for the treatment of immuno-inflammatory diseases and cancer, announced today the execution of an option agreement for acquisition by Almirall (ticker: ALM) including its lead